PetIQ (NASDAQ:PETQ) – Research analysts at William Blair issued their Q1 2018 earnings per share (EPS) estimates for shares of PetIQ in a report issued on Wednesday, March 14th, according to Zacks Investment Research. William Blair analyst J. Andersen expects that the company will post earnings of $0.24 per share for the quarter. William Blair also issued estimates for PetIQ’s Q2 2018 earnings at $0.33 EPS, Q3 2018 earnings at $0.22 EPS, Q4 2018 earnings at $0.10 EPS and FY2018 earnings at $0.88 EPS.
Several other research analysts have also issued reports on PETQ. Jefferies Group reiterated a “buy” rating and set a $27.00 price objective on shares of PetIQ in a research note on Monday, January 8th. Zacks Investment Research upgraded PetIQ from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a research note on Tuesday, January 9th. Finally, BidaskClub upgraded PetIQ from a “hold” rating to a “buy” rating in a research note on Tuesday, January 23rd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $27.50.
PetIQ stock traded down $0.87 during mid-day trading on Thursday, hitting $23.23. 430,153 shares of the company were exchanged, compared to its average volume of 566,356. The company has a debt-to-equity ratio of 0.17, a current ratio of 5.99 and a quick ratio of 3.56. PetIQ has a 1-year low of $17.03 and a 1-year high of $28.23. The firm has a market capitalization of $544.46 and a P/E ratio of 59.56.
PetIQ (NASDAQ:PETQ) last released its quarterly earnings data on Tuesday, March 13th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.14. The company had revenue of $51.93 million for the quarter, compared to analyst estimates of $51.63 million.
In other news, CEO Mccord Christensen sold 40,000 shares of the stock in a transaction on Monday, March 19th. The stock was sold at an average price of $24.92, for a total transaction of $996,800.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO John Newland sold 5,500 shares of the stock in a transaction on Monday, March 19th. The stock was sold at an average price of $24.83, for a total value of $136,565.00. The disclosure for this sale can be found here. Insiders have sold 65,500 shares of company stock worth $1,657,765 in the last 90 days.
Several hedge funds have recently made changes to their positions in PETQ. Eos Management L.P. bought a new position in PetIQ in the third quarter valued at about $143,836,000. Park West Asset Management LLC bought a new position in PetIQ in the fourth quarter valued at about $19,527,000. Wasatch Advisors Inc. bought a new position in PetIQ in the third quarter valued at about $7,229,000. Cooper Creek Partners Management LLC boosted its holdings in PetIQ by 192.3% in the fourth quarter. Cooper Creek Partners Management LLC now owns 366,801 shares of the company’s stock valued at $8,011,000 after acquiring an additional 241,292 shares during the last quarter. Finally, BlackRock Inc. boosted its holdings in PetIQ by 54.6% in the fourth quarter. BlackRock Inc. now owns 632,556 shares of the company’s stock valued at $13,815,000 after acquiring an additional 223,502 shares during the last quarter. Institutional investors own 37.02% of the company’s stock.
WARNING: This report was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/08/william-blair-weighs-in-on-petiq-incs-q1-2018-earnings-petq.html.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Get a free copy of the Zacks research report on PetIQ (PETQ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.